New Insights into the Regulation of Epithelial-Mesenchymal Transition and Tissue Fibrosis

International Review of Cell and Molecular Biology

Volumn 294, Issue , 2012, Pages 171-221

  Lee, KangAe ^a,b   Nelson, Celeste M ^a,b  

^a Princeton University   (United States)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

Epithelial plasticity; Epithelial mesenchymal transition; Fibrosis; Mechanotransduction; Myofibroblasts; Pathogenesis

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA CATENIN; CELL SURFACE PROTEIN; COLLAGEN TYPE 4; CYTOKINE; CYTOSKELETON PROTEIN; ERLOTINIB; GEFITINIB; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LAMININ; MATRIX METALLOPROTEINASE; MICRORNA; NEUTRALIZING ANTIBODY; OSTEOGENIC PROTEIN 1; OXYGEN; PROTEIN INHIBITOR; PROTEOME; REACTIVE OXYGEN METABOLITE; RECOMBINANT OSTEOGENIC PROTEIN 1; SCLEROPROTEIN; SMAD7 PROTEIN; SMALL INTERFERING RNA; SORAFENIB; SUNITINIB; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR INHIBITOR; UNCLASSIFIED DRUG; WNT PROTEIN;

ADVANCED CANCER; ANTISENSE THERAPY; ARTERY OCCLUSION; ARTICLE; CELL DIFFERENTIATION; CELL STRESS; CELL STRUCTURE; CHRONIC DISEASE; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FIBROBLAST; FIBROGENESIS; FIBROSIS; GENE CONTROL; GENE EXPRESSION REGULATION; GLOMERULOSCLEROSIS; HEART MUSCLE FIBROSIS; HUMAN; KIDNEY FAILURE; KIDNEY FIBROSIS; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER PROTECTION; LUNG FIBROSIS; MECHANICAL STRESS; MESENCHYME CELL; MICROENVIRONMENT; MORBIDITY; MORTALITY; MYOFIBROBLAST; NONHUMAN; OXYGEN TENSION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 84863183146     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394305-7.00004-5     Document Type: Chapter

References (302)

1. Abe R., Donnelly S.C., Peng T., Bucala R., Metz C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 2001, 166:7556-7562.
2. Acloque H., Adams M.S., Fishwick K., Bronner-Fraser M., Nieto M.A. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Invest. 2009, 119:1438-1449.
3. Alcaraz J., Xu R., Mori H., Nelson C.M., Mroue R., Spencer V.A., et al. Laminin and biomimetic extracellular elasticity enhance functional differentiation in mammary epithelia. EMBO J. 2008, 27:2829-2838.
4. Arendt L.M., Rudnick J.A., Keller P.J., Kuperwasser C. Stroma in breast development and disease. Semin. Cell Dev. Biol. 2010, 21:11-18.
5. Armstrong E.J., Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ. Res. 2004, 95:459-470.
6. Aybar M.J., Nieto M.A., Mayor R. Snail precedes Slug in the genetic cascade required for the specification and migration of the Xenopus neural crest. Development 2003, 130:483-494.
7. Baba S., Fujii H., Hirose T., Yasuchika K., Azuma H., Hoppo T., et al. Commitment of bone marrow cells to hepatic stellate cells in mouse. J. Hepatol. 2004, 40:255-260.
8. Bakin A.V., Tomlinson A.K., Bhowmick N.A., Moses H.L., Arteaga C.L. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 2000, 275:36803-36810.
9. Barnes J.L., Gorin Y. Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int. 2011, 79:944-956.
10. Barrallo-Gimeno A., Nieto M.A. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005, 132:3151-3161.
11. Barrios-Rodiles M., Brown K.R., Ozdamar B., Bose R., Liu Z., Donovan R.S., et al. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 2005, 307:1621-1625.
12. Basu R.K., Hubchak S., Hayashida T., Runyan C.E., Schumacker P.T., Schnaper H.W. Interdependence of HIF-1α and TGF-β/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression. Am. J. Physiol. Renal Physiol. 2011, 300:F898-F905.
13. Bates R.C., Bellovin D.I., Brown C., Maynard E., Wu B., Kawakatsu H., et al. Transcriptional activation of integrin β6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J. Clin. Invest. 2005, 115:339-347.
14. Bhowmick N.A., Ghiassi M., Bakin A., Aakre M., Lundquist C.A., Engel M.E., et al. Transforming growth factor-{beta}1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 2001, 12:27-36.
15. Birchmeier C., Birchmeier W., Gherardi E., Vande Woude G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 2003, 4:915-925.
16. Bolós V., Peinado H., Pérez-Moreno M.A., Fraga M.F., Esteller M., Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci. 2003, 116:499-511.
17. Bolós V., Peinado H., Pérez-Moreno M.A., Fraga M.F., Esteller M., Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci. 2003, 116:499-511.
18. Border W.A., Noble N.A., Yamamoto T., Harper J.R., Yamaguchi Y., Pierschbacher M.D., et al. Natural inhibitor of transforming growth factor-[beta] protects against scarring in experimental kidney disease. Nature 1992, 360:361-364.
19. Boutet A., De Frutos C.A., Maxwell P.H., Mayol M.J., Romero J., Nieto M.A. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J. 2006, 25:5603-5613.
20. Boyer B., Tucker G.C., Vallés A.M., Franke W.W., Thiery J.P. Rearrangements of desmosomal and cytoskeletal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder carcinoma cells. J. Cell Biol. 1989, 109:1495-1509.
21. Brakemeier S., Eichler I., Hopp H., Köhler R., Hoyer J. Up-regulation of endothelial stretch-activated cation channels by fluid shear stress. Cardiovasc. Res. 2002, 53:209-218.
22. Brembeck F.H., Schwarz-Romond T., Bakkers J., Wilhelm S., Hammerschmidt M., Birchmeier W. Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions. Genes Dev. 2004, 18:2225-2230.
23. Burk U., Schubert J., Wellner U., Schmalhofer O., Vincan E., Spaderna S., et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008, 9:582-589.
24. Butcher D.T., Alliston T., Weaver V.M. A tense situation: forcing tumour progression. Nat. Rev. Cancer 2009, 9:108-122.
25. Carpenter P.M., Wang-Rodriguez J., Chan O.T.M., Wilczynski S.P. Laminin 5 expression in metaplastic breast carcinomas. Am. J. Surg. Pathol. 2008, 32:345-353.
26. Casas E., Kim J., Bendesky A., Ohno-Machado L., Wolfe C.J., Yang J. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res. 2011, 71:245-254.
27. Cavallaro U., Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 2004, 4:118-132.
28. Chapman H.A. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu. Rev. Physiol. 2011, 73:413-435.
29. Chen C.S., Mrksich M., Huang S., Whitesides G.M., Ingber D.E. Geometric control of cell life and death. Science 1997, 276:1425-1428.
30. Chen Z.F., Behringer R.R. Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev. 1995, 9:686-699.
31. Cheng C.-W., Wu P.-E., Yu J.-C., Huang C.-S., Yue C.-T., Wu C.-W., et al. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 2001, 20:3814-3823.
32. Cheng G.Z., Chan J., Wang Q., Zhang W., Sun C.D., Wang L.-H. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res. 2007, 67:1979-1987.
33. Chess P.R., Toia L., Finkelstein J.N. Mechanical strain-induced proliferation and signaling in pulmonary epithelial H441 cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L43-L51.
34. Chilosi M., Poletti V., Zamò A., Lestani M., Montagna L., Piccoli P., et al. Aberrant Wnt/[beta]-catenin pathway activation in idiopathic pulmonary fibrosis. Am. J. Pathol. 2003, 162:1495-1502.
35. Chilosi M., Zamo A., Doglioni C., Reghellin D., Lestani M., Montagna L., et al. Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respir. Res. 2006, 7:95.
36. Chiquet M., Gelman L., Lutz R., Maier S. From mechanotransduction to extracellular matrix gene expression in fibroblasts. BBA-Mol. Cell Res. 2009, 1793:911-920.
37. Christ B., Ordahl C.P. Early stages of chick somite development. Anat. Embryol. 1995, 191:381-396.
38. Ciruna B., Rossant J. FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev. Cell 2001, 1:37-49.
39. Clerkin J.S., Naughton R., Quiney C., Cotter T.G. Mechanisms of ROS modulated cell survival during carcinogenesis. Cancer Lett. 2008, 266:30-36.
40. Colognato H., Yurchenco P.D. Form and function: the laminin family of heterotrimers. Dev. Dyn. 2000, 218:213-234.
41. Colucci-Guyon E., Portier M.-M., Dunia I., Paulin D., Pournin S., Babinet C. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 1994, 79:679-694.
42. Comijn J., Berx G., Vermassen P., Verschueren K., van Grunsven L., Bruyneel E., et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 2001, 7:1267-1278.
43. Conacci-Sorrell M., Simcha I., Ben-Yedidia T., Blechman J., Savagner P., Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherin-cadherin interactions. J. Cell Biol. 2003, 163:847-857.
44. Cordenonsi M., Montagner M., Adorno M., Zacchigna L., Martello G., Mamidi A., et al. Integration of TGF-ß and Ras/MAPK signaling through p53 phosphorylation. Science 2007, 315:840-843.
45. Cowden Dahl K.D., Robertson S.E., Weaver V.M., Simon M.C. Hypoxia-inducible factor regulates {alpha}v{beta}3 integrin cell surface expression. Mol. Biol. Cell 2005, 16:1901-1912.
46. Czirók A., Rongish B.J., Little C.D. Extracellular matrix dynamics during vertebrate axis formation. Dev. Biol. 2004, 268:111-122.
47. Damião M.J., Bertocchi A.P.F., Monteiro R.M.M., Gonçalves G.M., Cenedeze M.A., Feitoza C.Q., et al. The effects of rapamycin in the progression of renal fibrosis. Transplant. Proc. 2007, 39:457-459.
48. Daniel J.M., Reynolds A.B. Tyrosine phosphorylation and cadherin/catenin function. Bioessays 1997, 19:883-891.
49. Davidson L.A., Marsden M., Keller R., DeSimone D.W. Integrin α5β1 and fibronectin regulate polarized cell protrusions required for Xenopus convergence and extension. Curr. Biol. 2006, 16:833-844.
50. Davies M., Robinson M., Smith E., Huntley S., Prime S., Paterson I. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAPK, Smad and AP-1 signalling pathways. J. Cell. Biochem. 2005, 95:918-931.
51. Davis B.N., Hilyard A.C., Lagna G., Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61.
52. de Gouville A., Huet S. Inhibition of ALK5 as a new approach to treat liver fibrotic diseases. Drug News Perspect. 2006, 19:85-90.
53. del Barrio M.G., Nieto M.A. Overexpression of Snail family members highlights their ability to promote chick neural crest formation. Development 2002, 129:1583-1593.
54. del Rio A., Perez-Jimenez R., Liu R., Roca-Cusachs P., Fernandez J.M., Sheetz M.P. Stretching single talin rod molecules activates vinculin binding. Science 2009, 323:638-641.
55. Deng B., Yang X., Liu J., He F., Zhu Z., Zhang C. Focal adhesion kinase mediates TGF-β1-induced renal tubular epithelial-to-mesenchymal transition in vitro. Mol. Cell. Biochem. 2010, 340:21-29.
56. Dennerll T.J., Joshi H.C., Steel V.L., Buxbaum R.E., Heidemann S.R. Tension and compression in the cytoskeleton of PC-12 neurites. II: quantitative measurements. J. Cell Biol. 1988, 107:665-674.
57. Desmouliere A., Darby I.A., Gabbiani G. Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab. Invest. 2003, 83:1689-1707.
58. Díaz R., Kim J.W., Hui J.-J., Li Z., Swain G.P., Fong K.S.K., et al. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum. Pathol. 2008, 39:102-115.
59. Dickson M.C., Slager H.G., Duffie E., Mummery C.L., Akhurst R.J. RNA and protein localisations of TGF beta 2 in the early mouse embryo suggest an involvement in cardiac development. Development 1993, 117:625-639.
60. Ding Q., Xia W., Liu J.-C., Yang J.-Y., Lee D.-F., Xia J., et al. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-Catenin. Mol. Cell 2005, 19:159-170.
61. Dominguez D., Montserrat-Sentis B., Virgos-Soler A., Guaita S., Grueso J., Porta M., et al. Phosphorylation regulates the subcellular location and activity of the Snail transcriptional repressor. Mol. Cell. Biol. 2003, 23:5078-5089.
62. Dong R., Lu J.-G., Wang Q., He X.-L., Chu Y.-K., Ma Q.-J. Stabilization of Snail by HuR in the process of hydrogen peroxide induced cell migration. Biochem. Biophys. Res. Commun. 2007, 356:318-321.
63. Du J., Yang S., An D., Hu F., Yuan W., Zhai C., et al. BMP-6 inhibits microRNA-21 expression in breast cancer through repressing [delta]EF1 and AP-1. Cell Res. 2009, 19:487-496.
64. Dumont N., Wilson M.B., Crawford Y.G., Reynolds P.A., Sigaroudinia M., Tlsty T.D. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers. Proc. Natl. Acad. Sci. USA 2008, 105:14867-14872.
65. Eckert M.A., Lwin T.M., Chang A.T., Kim J., Danis E., Ohno-Machado L., et al. Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 2011, 19:372-386.
66. Eckes B., Colucci-Guyon E., Smola H., Nodder S., Babinet C., Krieg T., et al. Impaired wound healing in embryonic and adult mice lacking vimentin. J. Cell Sci. 2000, 113:2455-2462.
67. Edme N., Downward J., Thiery J.-P., Boyer B. Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways. J. Cell Sci. 2002, 115:2591-2601.
68. Egeblad M., Littlepage L., Werb Z. The fibroblastic coconspirator in cancer progression. Cold Spring Harb. Symp. Quant. Biol. 2005, 70:383-388.
69. Eger A., Aigner K., Sonderegger S., Dampier B., Oehler S., Schreiber M., et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005, 24:2375-2385.
70. Eisenberg L.M., Markwald R.R. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. Res. 1995, 77:1-6.
71. Elenbaas B., Weinberg R.A. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 2001, 264:169-184.
72. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
73. Ferraro D., Corso S., Fasano E., Panieri E., Santangelo R., Borrello S., et al. Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS). Oncogene 2006, 25:3689-3698.
74. Fiaschi T., Cozzi G., Raugei G., Formigli L., Ramponi G., Chiarugi P. Redox regulation of β-actin during integrin-mediated cell adhesion. J. Biol. Chem. 2006, 281:22983-22991.
75. Franco H.L., Casasnovas J., Rodríguez-Medina J.R., Cadilla C.L. Redundant or separate entities?-roles of Twist1 and Twist2 as molecular switches during gene transcription. Nucleic Acids Res. 2011, 39:1177-1186.
76. Funayama N., Sato Y., Matsumoto K., Ogura T., Takahashi Y. Coelom formation: binary decision of the lateral plate mesoderm is controlled by the ectoderm. Development 1999, 126:4129-4138.
77. Galichon P., Hertig A. Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside?. Fibrogenesis Tissue Repair 2011, 4:11.
78. Gavert N., Ben-Ze'ev A. β-Catenin signaling in biological control and cancer. J. Cell. Biochem. 2007, 102:820-828.
79. Gebeshuber C.A., Zatloukal K., Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep. 2009, 10:400-405.
80. Giancotti F.G., Ruoslahti E. Integrin signaling. Science 1999, 285:1028-1033.
81. Giri S., Hyde D., Hollinger M. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax 1993, 48:956-966.
82. Gjorevski N., Boghaert E., Nelson C. Regulation of epithelial-mesenchymal transition by transmission of mechanical stress through epithelial tissues. Cancer Microenviron. 2011, 1-10.
83. Gjorevski N., Nelson C.M. Endogenous patterns of mechanical stress are required for branching morphogenesis. Integr. Biol. 2010, 2:424-434.
84. Goldsmith E.C., Zhang X., Watson J., Hastings J., Potts J.D. The collagen receptor DDR2 is expressed during early cardiac development. Anat. Rec. 2010, 293:762-769.
85. Gomez E.W., Chen Q.K., Gjorevski N., Nelson C.M. Tissue geometry patterns epithelial-mesenchymal transition via intercellular mechanotransduction. J. Cell. Biochem. 2010, 110:44-51.
86. Gort E.H., van Haaften G., Verlaan I., Groot A.J., Plasterk R.H.A., Shvarts A., et al. The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2[alpha]. Oncogene 2007, 27:1501-1510.
87. Goumans M.-J., van Zonneveld A.J., ten Dijke P. Transforming Growth Factor [beta]-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis?. Trends Cardiovasc. Med. 2008, 18:293-298.
88. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10:593-601.
89. Gressner O., Weiskirchen R., Gressner A. Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp. Hepatol. 2007, 6:7.
90. Grillo H.C. Origin of fibroblasts in wound healing an autoradiographic study of inhibition of cellular proliferation by local X-irradiation. Ann. Surg. 1963, 157:453-467.
91. Grimes H., Chan T., Zweidler-McKay P., Tong B., Tsichlis P. The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol. Cell. Biol. 1996, 16:6263-6272.
92. Grotegut S., von Schweinitz D., Christofori G., Lehembre F. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J. 2006, 25:3534-3545.
93. Guarino M., Tosoni A., Nebuloni M. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition. Hum. Pathol. 2009, 40:1365-1376.
94. Gurtner G.C., Werner S., Barrandon Y., Longaker M.T. Wound repair and regeneration. Nature 2008, 453:314-321.
95. Haase V.H. Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to disease. Kidney Int. 2009, 76:492-499.
96. Hardy K., Booth B., Hendrix M., Salomon D., Strizzi L. ErbB/EGF signaling and EMT in mammary development and breast cancer. J. Mammary Gland Biol. 2010, 15:191-199.
97. Hashimoto N., Phan S.H., Imaizumi K., Matsuo M., Nakashima H., Kawabe T., et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2010, 43:161-172.
98. Heatley M., Whiteside C., Maxwell P., Toner P. Vimentin expression in benign and malignant breast epithelium. J. Clin. Pathol. 1993, 46:441-445.
99. Heise R.L., Stober V., Cheluvaraju C., Hollingsworth J.W., Garantziotis S. Mechanical stretch induces epithelial-mesenchymal transition in alveolar epithelia via hyaluronan activation of innate immunity. J. Biol. Chem. 2011, 286:17435-17444.
100. Helmke B.P., Rosen A.B., Davies P.F. Mapping mechanical strain of an endogenous cytoskeletal network in living endothelial cells. Biophys. J. 2003, 84:2691-2699.
101. Herranz N., Pasini D., Diaz V.M., Franci C., Gutierrez A., Dave N., et al. Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol. Cell. Biol. 2008, 28:4772-4781.
102. Hertig A., Anglicheau D., Verine J., Pallet N., Touzot M., Ancel P.-Y., et al. Early epithelial phenotypic changes predict graft fibrosis. J. Am. Soc. Nephrol. 2008, 19:1584-1591.
103. Higgins D.F., Biju M.P., Akai Y., Wutz A., Johnson R.S., Haase V.H. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am. J. Physiol. Renal Physiol. 2004, 287:F1223-F1232.
104. Higgins D.F., Kimura K., Iwano M., Haase V.H. Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle 2008, 7:1128-1132.
105. Hinz B. Tissue stiffness, latent TGF-β1 Activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis. Curr. Rheumatol. Rep. 2009, 11:120-126.
106. Hinz B. The myofibroblast: paradigm for a mechanically active cell. J. Biomech. 2010, 43:146-155.
107. Hoffman B.D., Grashoff C., Schwartz M.A. Dynamic molecular processes mediate cellular mechanotransduction. Nature 2011, 475:316-323.
108. Hollande F., Blanc E.M., Bali J.P., Whitehead R.H., Pelegrin A., Baldwin G.S., et al. HGF regulates tight junctions in new nontumorigenic gastric epithelial cell line. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280:G910-G921.
109. Hou Z., Peng H., Ayyanathan K., Yan K.-P., Langer E.M., Longmore G.D., et al. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol. Cell. Biol. 2008, 28:3198-3207.
110. Hsu T., Trojanowska M., Watson D.K. Ets proteins in biological control and cancer. J. Cell. Biochem. 2004, 91:896-903.
111. Huang Y., Border W.A., Noble N.A. Perspectives on blockade of TGF[beta] overexpression. Kidney Int. 2006, 69:1713-1714.
112. Imai T., Horiuchi A., Wang C., Oka K., Ohira S., Nikaido T., et al. Hypoxia attenuates the expression of E-cadherin via up-regulation of Snail in ovarian carcinoma cells. Am. J. Pathol. 2003, 163:1437-1447.
113. Isaka Y., Akagi Y., Ando Y., Tsujie M., Sudo T., Ohno N., et al. Gene therapy by transforming growth factor-[bgr] receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int. 1999, 55:465-475.
114. Isaka Y., Tsujie M., Ando Y., Nakamura H., Kaneda Y., Imai E., et al. Transforming growth factor-[bgr]1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int. 2000, 58:1885-1892.
115. Ishigaki Y., Nakamura Y., Takehara T., Shimasaki T., Tatsuno T., Takano F., et al. Scanning electron microscopy with an ionic liquid reveals the loss of mitotic protrusions of cells during the epithelial-mesenchymal transition. Microsc. Res. Tech. 2011, 74:1024-1031.
116. Ishii Y., Fujimoto S., Fukuda T. Gefitinib prevents bleomycin-induced lung fibrosis in mice. Am. J. Respir. Crit. Care Med. 2006, 174:550-556.
117. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., Neilson E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 2002, 110:341-350.
118. Jo M., Lester R.D., Montel V., Eastman B., Takimoto S., Gonias S.L. Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling. J. Biol. Chem. 2009, 284:22825-22833.
119. Johar K., Vasavada A.R., Tatsumi K., Dholakia S., Nihalani B., Rao S.S.L. Anterior capsular plaque in congenital cataract: occurrence, morphology, immunofluorescence, and ultrastructure. Invest. Ophthalmol. Vis. Sci. 2007, 48:4209-4214.
120. Kaidi A., Williams A.C., Paraskeva C. Interaction between [beta]-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell Biol. 2007, 9:210-217.
121. Kaimori A., Potter J., Kaimori J.-Y., Wang C., Mezey E., Koteish A. Transforming growth factor-β1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J. Biol. Chem. 2007, 282:22089-22101.
122. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 2003, 112:1776-1784.
123. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
124. Kataoka H., Murayama T., Yokode M., Mori S., Sano H., Ozaki H., et al. A novel Snail-related transcription factor Smuc regulates basic helix-loop-helix transcription factor activities via specific E-box motifs. Nucleic Acids Res. 2000, 28:626-633.
125. Keely P.J. Rho GTPases as early markers for tumour progression. Lancet 2001, 358:1744-1745.
126. Keely P.J., Westwick J.K., Whitehead I.P., Der C.J., Parise L.V. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 1997, 390:632-636.
127. Kida Y., Asahina K., Teraoka H., Gitelman I., Sato T. Twist relates to tubular epithelial-mesenchymal transition and interstitial fibrogenesis in the obstructed kidney. J. Histochem. Cytochem. 2007, 55:661-673.
128. Kim K.K., Kugler M.C., Wolters P.J., Robillard L., Galvez M.G., Brumwell A.N., et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl. Acad. Sci. USA 2006, 103:13180-13185.
129. Kim Y., Mio T., Mishima M. Gefitinib for non-small cell lung cancer patients with liver cirrhosis. Intern. Med. 2009, 48:1677-1679.
130. Kinoshita K., Iimuro Y., Otogawa K., Saika S., Inagaki Y., Nakajima Y., et al. Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut 2007, 56:706-714.
131. Kisanuki Y.Y., Hammer R.E., Miyazaki J.-I., Williams S.C., Richardson J.A., Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 2001, 230:230-242.
132. Kitao A., Sato Y., Sawada-Kitamura S., Harada K., Sasaki M., Morikawa H., et al. Endothelial to mesenchymal transition via transforming growth factor-[beta]1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension. Am. J. Pathol. 2009, 175:616-626.
133. Kondo M., Cubillo E., Tobiume K., Shirakihara T., Fukuda N., Suzuki H., et al. A role for Id in the regulation of TGF-[beta]-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ. 2004, 11:1092-1101.
134. Kong W., Yang H., He L., Zhao J.-J., Coppola D., Dalton W.S., et al. MicroRNA-155 is regulated by the transforming growth factor {beta}/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 2008, 28:6773-6784.
135. Kota J., Chivukula R.R., O'Donnell K.A., Wentzel E.A., Montgomery C.L., Hwang H.-W., et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137:1005-1017.
136. Krieg M., Arboleda-Estudillo Y., Puech P.H., Kafer J., Graner F., Muller D.J., et al. Tensile forces govern germ-layer organization in zebrafish. Nat. Cell Biol. 2008, 10:429-436.
137. Krishnamachary B., Zagzag D., Nagasawa H., Rainey K., Okuyama H., Baek J.H., et al. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res. 2006, 66:2725-2731.
138. Kume T., Deng K., Hogan B.L. Murine forkhead/winged helix genes Foxc1 (Mf1) and Foxc2 (Mfh1) are required for the early organogenesis of the kidney and urinary tract. Development 2000, 127:1387-1395.
139. Lan H.Y., Mu W., Tomita N., Huang X.R., Li J.H., Zhu H.-J., et al. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J. Am. Soc. Nephrol. 2003, 14:1535-1548.
140. Lee K., Gjorevski N., Boghaert E., Radisky D.C., Nelson C.M. Snail, Slug, and E47 promote mammary epithelial branching morphogenesis. EMBO J. 2011, in press.
141. Lee K., Lynd J.D., O'Reilly S., Kiupel M., McCormick J.J., LaPres J.J. The biphasic role of the hypoxia-inducible factor prolyl-4-hydroxylase, PHD2, in modulating tumor-forming potential. Mol. Cancer Res. 2008, 6:829-842.
142. Lee K., Roth R.A., LaPres J.J. Hypoxia, drug therapy and toxicity. Pharmacol. Ther. 2007, 113:229-246.
143. Lee K., Zhang H., Qian D.Z., Rey S., Liu J.O., Semenza G.L. Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proc. Natl. Acad. Sci. USA 2009, 106:17910-17915.
144. Leptin M. Twist and snail as positive and negative regulators during Drosophila mesoderm development. Genes Dev. 1991, 5:1568-1576.
145. Leroy P., Mostov K.E. Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. Mol. Biol. Cell 2007, 18:1943-1952.
146. Levental K.R., Yu H., Kass L., Lakins J.N., Egeblad M., Erler J.T., et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906.
147. Li Y., Yang J., Dai C., Wu C., Liu Y. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J. Clin. Invest. 2003, 112:503-516.
148. Lim S.-O., Gu J.-M., Kim M.S., Kim H.-S., Park Y.N., Park C.K., et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 2008, 135:2128-2140. 2140.e1-8.
149. Liu J., Uygur B., Zhang Z., Shao L., Romero D., Vary C., et al. Slug inhibits proliferation of human prostate cancer cells via downregulation of cyclin D1 expression. Prostate 2010, 70:1768-1777.
150. Liu X., Hu H., Yin J.Q. Therapeutic strategies against TGF-β signaling pathway in hepatic fibrosis. Liver Int. 2006, 26:8-22.
151. Lo H.-W., Hsu S.-C., Xia W., Cao X., Shih J.-Y., Wei Y., et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 2007, 67:9066-9076.
152. Locascio A., Nieto M.A. Cell movements during vertebrate development: integrated tissue behaviour versus individual cell migration. Curr. Opin. Genet. Dev. 2001, 11:464-469.
153. Lochter A., Galosy S., Muschler J., Freedman N., Werb Z., Bissell M.J. Matrix metalloproteinase Stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 1997, 139:1861-1872.
154. Lombaerts M., van Wezel T., Philippo K., Dierssen J.W.F., Zimmerman R.M.E., Oosting J., et al. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br. J. Cancer 2006, 94:661-671.
155. López-Novoa J.M., Nieto M.A. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol. Med. 2009, 1:303-314.
156. Lopez J.I., Kang I., You W.-K., McDonald D.M., Weaver V.M. In situ force mapping of mammary gland transformation. Integr. Biol. 2011, 3:910-921.
157. Lu J., Landerholm T.E., Wei J.S., Dong X.-R., Wu S.-P., Liu X., et al. Coronary smooth muscle differentiation from proepicardial cells requires RhoA-mediated actin reorganization and p160 Rho-kinase activity. Dev. Biol. 2001, 240:404-418.
158. Lu Z., Ghosh S., Wang Z., Hunter T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of β-catenin, and enhanced tumor cell invasion. Cancer Cell 2003, 4:499-515.
159. Ma L., Teruya-Feldstein J., Weinberg R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449:682-688.
160. Ma L., Young J., Prabhala H., Pan E., Mestdagh P., Muth D., et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 2010, 12:247-256.
161. MacPherson M.R., Molina P., Souchelnytskyi S., Wernstedt C., Martin-Perez J., Portillo F., et al. Phosphorylation of serine 11 and serine 92 as new positive regulators of human Snail1 function: potential involvement of Casein Kinase-2 and the cAMP-activated Kinase Protein Kinase A. Mol. Biol. Cell 2010, 21:244-253.
162. Mani S.A., Yang J., Brooks M., Schwaninger G., Zhou A., Miura N., et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc. Natl. Acad. Sci. USA 2007, 104:10069-10074.
163. Maskarinec G., Woolcott C.G., Kolonel L.N. Mammographic density as a predictor of breast cancer outcome. Future Oncol. 2010, 6:351-354.
164. Masszi A., Di Ciano C., Sirokmány G., Arthur W.T., Rotstein O.D., Wang J., et al. Central role for Rho in TGF-β1-induced α-smooth muscle actin expression during epithelial-mesenchymal transition. Am. J. Physiol. Renal Physiol. 2003, 284:F911-F924.
165. McAnulty R.J. Fibroblasts and myofibroblasts: their source, function and role in disease. Int. J. Biochem. Cell Biol. 2007, 39:666-671.
166. McBride S.H., Falls T., Knothe Tate M.L. Modulation of stem cell shape and fate B: mechanical modulation of cell shape and gene expression. Tissue Eng. Part A 2008, 14:1573-1580.
167. Mejias M., Garcia-Pras E., Tiani C., Miquel R., Bosch J., Fernandez M. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 2009, 49:1245-1256.
168. Menke A., Philippi C., Vogelmann R., Seidel B., Lutz M.P., Adler G., et al. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. Cancer Res. 2001, 61:3508-3517.
169. Miele L. Notch signaling. Clin. Cancer Res. 2006, 12:1074-1079.
170. Miyazawa K., Iwaya K., Kuroda M., Harada M., Serizawa H., Koyanagi Y., et al. Nuclear accumulation of beta-catenin in intestinal-type gastric carcinoma: correlation with early tumor invasion. Virchows Arch. 2000, 437:508-513.
171. Moinfar F., Man Y.G., Arnould L., Bratthauer G.L., Ratschek M., Tavassoli F.A. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res. 2000, 60:2562-2566.
172. Mori K., Shibanuma M., Nose K. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res. 2004, 64:7464-7472.
173. Moustakas A., Heldin C.-H. Non-Smad TGF-β signals. J. Cell Sci. 2005, 118:3573-3584.
174. Nadasdy T., Laszik Z., Blick K.E., Johnson D.L., Silva F.G. Tubular atrophy in the end-stage kidney: a lectin and immunohistochemical study. Hum. Pathol. 1994, 25:22-28.
175. Nakagawa S., Takeichi M. Neural crest cell-cell adhesion controlled by sequential and subpopulation-specific expression of novel cadherins. Development 1995, 121:1321-1332.
176. Nakagawa S., Takeichi M. Neural crest emigration from the neural tube depends on regulated cadherin expression. Development 1998, 125:2963-2971.
177. Nakajima Y., Mironov V., Yamagishi T., Nakamura H., Markwald R.R. Expression of smooth muscle alpha-actin in mesenchymal cells during formation of avian endocardial cushion tissue: a role for transforming growth factor β3. Dev. Dyn. 1997, 209:296-309.
178. Nakajima Y., Miyazono K., Kato M., Takase M., Yamagishi T., Nakamura H. Extracellular fibrillar structure of latent TGFβ binding protein-1: role in TGFβ-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse embryonic heart. J. Cell Biol. 1997, 136:193-204.
179. Nakajima Y., Yamagishi T., Hokari S., Nakamura H. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-β and bone morphogenetic protein (BMP). Anat. Rec. 2000, 258:119-127.
180. Nakajima Y., Yamagishi T., Nakamura H., Markwald R.R., Krug E.L. An autocrine function for transforming growth factor (TGF)-[beta]3 in the transformation of atrioventricular canal endocardium into mesenchyme during chick heart development. Dev. Biol. 1998, 194:99-113.
181. Nakano Y., Oyamada M., Dai P., Nakagami T., Kinoshita S., Takamatsu T. Connexin43 knockdown accelerates wound healing but inhibits mesenchymal transition after corneal endothelial injury in vivo. Invest. Ophthalmol. Vis. Sci. 2008, 49:93-104.
182. Nawshad A., LaGamba D., Polad A., Hay E.D. Transforming Growth Factor-β signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs 2005, 179:11-23.
183. Nelson C.M., Jean R.P., Tan J.L., Liu W.F., Sniadecki N.J., Spector A.A., et al. Emergent patterns of growth controlled by multicellular form and mechanics. Proc. Natl. Acad. Sci. USA 2005, 102:11594-11599.
184. Nelson C.M., Khauv D., Bissell M.J., Radisky D.C. Change in cell shape is required for matrix metalloproteinase-induced epithelial-mesenchymal transition of mammary epithelial cells. J. Cell. Biochem. 2008, 105:25-33.
185. Nelson C.M., VanDuijn M.M., Inman J.L., Fletcher D.A., Bissell M.J. Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science 2006, 314:298-300.
186. Nelson W.J., Nusse R. Convergence of Wnt, ß-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
187. Niessen K., Fu Y., Chang L., Hoodless P.A., McFadden D., Karsan A. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J. Cell Biol. 2008, 182:315-325.
188. Nieto M.A. The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell Biol. 2002, 3:155-166.
189. Niimi H., Pardali K., Vanlandewijck M., Heldin C.-H., Moustakas A. Notch signaling is necessary for epithelial growth arrest by TGF-β. J. Cell Biol. 2007, 176:695-707.
190. Nimnual A.S., Taylor L.J., Bar-Sagi D. Redox-dependent downregulation of Rho by Rac. Nat. Cell Biol. 2003, 5:236-241.
191. Noseda M., McLean G., Niessen K., Chang L., Pollet I., Montpetit R., et al. Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ. Res. 2004, 94:910-917.
192. Novo E., Parola M. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 2008, 1:5.
193. Okada H., Ban S., Nagao S., Takahashi H., Suzuki H., Neilson E.G. Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int. 2000, 58:587-597.
194. Olumi A.F., Grossfeld G.D., Hayward S.W., Carroll P.R., Tlsty T.D., Cunha G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999, 59:5002-5011.
195. Omenetti A., Porrello A., Jung Y., Yang L., Popov Y., Choi S.S., et al. Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J. Clin. Invest. 2008, 118:3331-3342.
196. Ortega S., Ittmann M., Tsang S.H., Ehrlich M., Basilico C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl. Acad. Sci. USA 1998, 95:5672-5677.
197. Pajerowski J.D., Dahl K.N., Zhong F.L., Sammak P.J., Discher D.E. Physical plasticity of the nucleus in stem cell differentiation. Proc. Natl. Acad. Sci. USA 2007, 104:15619-15624.
198. Park S.-M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008, 22:894-907.
199. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254.
200. Peinado H., Ballestar E., Esteller M., Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/Histone Deacetylase 1 (HDAC1)/HDAC2 complex. Mol. Cell. Biol. 2004, 24:306-319.
201. Peinado H., del Carmen Iglesias-de la Cruz M., Olmeda D., Csiszar K., Fong K.S.K., Vega S., et al. A molecular role for lysyl oxidase-like 2 enzyme in Snail regulation and tumor progression. EMBO J. 2005, 24:3446-3458.
202. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 2007, 7:415-428.
203. Peinado H., Portillo F., Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol. 2004, 48:365-375.
204. Peinado H., Quintanilla M., Cano A. Transforming growth factor β-1 induces Snail transcription factor in epithelial cell lines. J. Biol. Chem. 2003, 278:21113-21123.
205. Pennacchietti S., Michieli P., Galluzzo M., Mazzone M., Giordano S., Comoglio P.M. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003, 3:347-361.
206. Pérez-Moreno M.A., Locascio A., Rodrigo I., Dhondt G., Portillo F., Nieto M.A., et al. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J. Biol. Chem. 2001, 276:27424-27431.
207. Petersen O.W., Nielsen H.L., Gudjonsson T., Villadsen R., Rank F., Niebuhr E., et al. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am. J. Pathol. 2003, 162:391-402.
208. Phillips R.J., Burdick M.D., Hong K., Lutz M.A., Murray L.A., Xue Y.Y., et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 2004, 114:438-446.
209. Piechocki M.P., Dibbley S.K., Lonardo F., Yoo G.H. Gefitinib prevents cancer progression in mice expressing the activated rat HER2/neu. Int. J. Cancer 2008, 122:1722-1729.
210. Plotkin L.I., Mathov I., Aguirre J.I., Parfitt A.M., Manolagas S.C., Bellido T. Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs. Am. J. Physiol. Cell Physiol. 2005, 289:C633-C643.
211. Poli G., Leonarduzzi G., Biasi F., Chiarpotto E. Oxidative stress and cell signalling. Curr. Med. Chem. 2004, 11:1163-1182.
212. Powell D.W., Mifflin R.C., Valentich J.D., Crowe S.E., Saada J.I., West A.B. Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. Cell Physiol. 1999, 277:C1-C19.
213. Powell D.W., Pinchuk I.V., Saada J.I., Chen X., Mifflin R.C. Mesenchymal cells of the intestinal lamina propria. Annu. Rev. Physiol. 2011, 73:213-237.
214. Qian F., Zhang Z.-C., Wu X.-F., Li Y.-P., Xu Q. Interaction between integrin [alpha]5 and fibronectin is required for metastasis of B16F10 melanoma cells. Biochem. Biophys. Res. Commun. 2005, 333:1269-1275.
215. Radisky D.C., Kenny P.A., Bissell M.J. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?. J. Cell. Biochem. 2007, 101:830-839.
216. Radisky D.C., Levy D.D., Littlepage L.E., Liu H., Nelson C.M., Fata J.E., et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005, 436:123-127.
217. Rastaldi M.P., Ferrario F., Giardino L., Dell'Antonio G., Grillo C., Grillo P., et al. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int. 2002, 62:137-146.
218. Redell M.S., Tweardy D.J. Targeting transcription factors in cancer: challenges and evolving strategies. Drug Discov. Today: Technol. 2006, 3:261-267.
219. Rhyu D.Y., Yang Y., Ha H., Lee G.T., Song J.S., Uh S.-T., et al. Role of reactive oxygen species in TGF-β1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J. Am. Soc. Nephrol. 2005, 16:667-675.
220. Rosivatz E., Becker I., Specht K., Fricke E., Luber B., Busch R., et al. Differential expression of the epithelial-mesenchymal transition regulators Snail, SIP1, and Twist in gastric cancer. Am. J. Pathol. 2002, 161:1881-1891.
221. Ruiz S.A., Chen C.S. Emergence of patterned stem cell differentiation within multicellular structures. Stem Cells 2008, 26:2921-2927.
222. Sahlgren C., Gustafsson M.V., Jin S., Poellinger L., Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl. Acad. Sci. USA 2008, 105:6392-6397.
223. Saika S., Yamanaka O., Flanders K., Okada Y., Miyamoto T., Sumioka T., et al. Epithelial-mesenchymal transition as a therapeutic target for prevention of ocular tissue fibrosis. Endocr. Metab. Immune Disord. Drug Targets 2008, 8:69-76.
224. Saika S., Yamanaka O., Sumioka T., Miyamoto T., Miyazaki K.-I., Okada Y., et al. Fibrotic disorders in the eye: targets of gene therapy. Prog. Retin. Eye Res. 2008, 27:177-196.
225. Saini Y., Harkema J.R., LaPres J.J. HIF1α is essential for normal intrauterine differentiation of alveolar epithelium and surfactant production in the newborn lung of mice. J. Biol. Chem. 2008, 283:33650-33657.
226. Sakai D., Suzuki T., Osumi N., Wakamatsu Y. Cooperative action of Sox9, Snail2 and PKA signaling in early neural crest development. Development 2006, 133:1323-1333.
227. Sánchez-Elsner T., Botella L.M., Velasco B., Corbi{dotless} A., Attisano L., Bernabéu C. Synergistic cooperation between hypoxia and transforming growth factor-β pathways on human vascular endothelial growth factor gene expression. J. Biol. Chem. 2001, 276:38527-38535.
228. Sanford L.P., Ormsby I., Gittenberger-de Groot A.C., Sariola H., Friedman R., Boivin G.P., et al. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 1997, 124:2659-2670.
229. Sarrió D., Rodriguez-Pinilla S.M., Hardisson D., Cano A., Moreno-Bueno G., Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 2008, 68:989-997.
230. Savagner P., Yamada K.M., Thiery J.P. The zinc-finger protein Slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J. Cell Biol. 1997, 137:1403-1419.
231. Sawada Y., Tamada M., Dubin-Thaler B.J., Cherniavskaya O., Sakai R., Tanaka S., et al. Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell 2006, 127:1015-1026.
232. Scarpa M., Grillo A.R., Brun P., Macchi V., Stefani A., Signori S., et al. Snail1 transcription factor is a critical mediator of hepatic stellate cell activation following hepatic injury. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300:G316-G326.
233. Schedin P., Keely P.J. Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb. Perspect. Biol. 2011, 3:a003228.
234. Sefton M., Sanchez S., Nieto M.A. Conserved and divergent roles for members of the Snail family of transcription factors in the chick and mouse embryo. Development 1998, 125:3111-3121.
235. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721-732.
236. Sharma K., Jin Y., Guo J., Ziyadeh F. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996, 45:522-530.
237. Shi-Wen X., Leask A., Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 2008, 19:133-144.
238. Shi Q., Boettiger D. A novel mode for integrin-mediated signaling: tethering is required for phosphorylation of FAK Y397. Mol. Biol. Cell 2003, 14:4306-4315.
239. Shintani Y., Maeda M., Chaika N., Johnson K.R., Wheelock M.J. Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-β signaling. Am. J. Resp. Cell Mol. 2008, 38:95-104.
240. Shirakihara T., Saitoh M., Miyazono K. Differential regulation of epithelial and mesenchymal markers by {delta}EF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol. Biol. Cell 2007, 18:3533-3544.
241. Shook D., Keller R. Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech. Dev. 2003, 120:1351-1383.
242. Slattery C., McMorrow T., Ryan M.P. Overexpression of E2A proteins induces epithelial-mesenchymal transition in human renal proximal tubular epithelial cells suggesting a potential role in renal fibrosis. FEBS Lett. 2006, 580:4021-4030.
243. Smith M.L., Gourdon D., Little W.C., Kubow K.E., Eguiluz R.A., Luna-Morris S., et al. Force-induced unfolding of fibronectin in the extracellular matrix of living cells. PLoS Biol. 2007, 5:e268.
244. Strutz F., Okada H., Lo C.W., Danoff T., Carone R.L., Tomaszewski J.E., et al. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 1995, 130:393-405.
245. Sugimoto H., Yang C., LeBleu V.S., Soubasakos M.A., Giraldo M., Zeisberg M., et al. BMP-7 functions as a novel hormone to facilitate liver regeneration. FASEB J. 2007, 21:256-264.
246. Tamada M., Sheetz M.P., Sawada Y. Activation of a signaling cascade by cytoskeleton stretch. Dev. Cell 2004, 7:709-718.
247. Tamariz E., Grinnell F. Modulation of fibroblast morphology and adhesion during collagen matrix remodeling. Mol. Biol. Cell 2002, 13:3915-3929.
248. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
249. Thiery J.P., Acloque H., Huang R.Y.J., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
250. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7:131-142.
251. Thuault S., Valcourt U., Petersen M., Manfioletti G., Heldin C.-H., Moustakas A. Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition. J. Cell Biol. 2006, 174:175-183.
252. Timmerman L.A., Grego-Bessa J., Raya A., Bertrán E., Pérez-Pomares J.M., Díez J., et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004, 18:99-115.
253. Tugues S., Fernandez-Varo G., Muñoz-Luque J., Ros J., Arroyo V., Rodés J., et al. Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats. Hepatology 2007, 46:1919-1926.
254. Turner N., Grose R. Fibroblast growth factor signalling: from development to cancer. Nat. Rev. Cancer 2010, 10:116-129.
255. Vallés A.M., Beuvin M., Boyer B. Activation of Rac1 by paxillin-Crk-DOCK180 signaling complex is antagonized by Rap1 in migrating NBT-II cells. J. Biol. Chem. 2004, 279:44490-44496.
256. Vandewalle C., Comijn J., De Craene B., Vermassen P., Bruyneel E., Andersen H., et al. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 2005, 33:6566-6578.
257. Vandewalle C., Van Roy F., Berx G. The role of the ZEB family of transcription factors in development and disease. Cell. Mol. Life Sci. 2009, 66:773-787.
258. Vega S., Morales A.V., Ocaña O.H., Valdés F., Fabregat I., Nieto M.A. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev. 2004, 18:1131-1143.
259. Vernon A.E., LaBonne C. Slug stability is dynamically regulated during neural crest development by the F-box protein Ppa. Development 2006, 133:3359-3370.
260. Vetter G., Le Béchec A., Muller J., Muller A., Moes M., Yatskou M., et al. Time-resolved analysis of transcriptional events during SNAI1-triggered epithelial to mesenchymal transition. Biochem. Biophys. Res. Commun. 2009, 385:485-491.
261. Vogel V., Sheetz M. Local force and geometry sensing regulate cell functions. Nat. Rev. Mol. Cell Biol. 2006, 7:265-275.
262. Vogel W., Gish G.D., Alves F., Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell 1997, 1:13-23.
263. Wang H.-R., Zhang Y., Ozdamar B., Ogunjimi A.A., Alexandrova E., Thomsen G.H., et al. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 2003, 302:1775-1779.
264. Wang S.-P., Wang W.-L., Chang Y.-L., Wu C.-T., Chao Y.-C., Kao S.-H., et al. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat. Cell Biol. 2009, 11:694-704.
265. Wang Z., Li Y., Kong D., Sarkar F. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr. Drug Targets 2010, 11:745-751.
266. Werner E., Werb Z. Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases. J. Cell Biol. 2002, 158:357-368.
267. White L.R., Blanchette J.B., Ren L., Awn A., Trpkov K., Muruve D.A. The characterization of α5-integrin expression on tubular epithelium during renal injury. Am. J. Physiol. Renal Physiol. 2007, 292:F567-F576.
268. Wienholds E., Koudijs M.J., van Eeden F.J.M., Cuppen E., Plasterk R.H.A. The microRNA-producing enzyme Dicer1 is essential for zebrafish development. Nat. Genet. 2003, 35:217-218.
269. Willis B.C., Liebler J.M., Luby-Phelps K., Nicholson A.G., Crandall E.D., du Bois R.M., et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-[beta]1: potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 2005, 166:1321-1332.
270. Wolf Y.G., Rasmussen L.M., Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J. Clin. Invest. 1994, 93:1172-1178.
271. Wu W.-S., Heinrichs S., Xu D., Garrison S.P., Zambetti G.P., Adams J.M., et al. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 2005, 123:641-653.
272. Wu Y., Evers B.M., Zhou B.P. Small C-terminal domain phosphatase enhances Snail activity through dephosphorylation. J. Biol. Chem. 2009, 284:640-648.
273. Wynn T.A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 2007, 117:524-529.
274. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214:199-210.
275. Xia H., Ng S.S., Jiang S., Cheung W.K.C., Sze J., Bian X.-W., et al. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem. Biophys. Res. Commun. 2010, 391:535-541.
276. Xu J., Lamouille S., Derynck R. TGF-[beta]-induced epithelial to mesenchymal transition. Cell Res. 2009, 19:156-172.
277. Xue C., Plieth D., Venkov C., Xu C., Neilson E.G. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res. 2003, 63:3386-3394.
278. Yamamoto T., Takagawa S., Katayama I., Nishioka K. Anti-sclerotic effect of transforming growth factor-[beta] antibody in a mouse model of bleomycin-induced scleroderma. Clin. Immunol. 1999, 92:6-13.
279. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
280. Yang L., Lin C., Liu Z.-R. P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing axin from β-catenin. Cell 2006, 127:139-155.
281. Yang M.-H., Wu M.-Z., Chiou S.-H., Chen P.-M., Chang S.-Y., Liu C.-J., et al. Direct regulation of TWIST by HIF-1[alpha] promotes metastasis. Nat. Cell Biol. 2008, 10:295-305.
282. Yang Z., Rayala S., Nguyen D., Vadlamudi R.K., Chen S., Kumar R. Pak1 phosphorylation of Snail, a master regulator of epithelial-to-mesenchyme transition, modulates Snail's subcellular localization and functions. Cancer Res. 2005, 65:3179-3184.
283. Yang Z., Zhang X., Gang H., Li X., Li Z., Wang T., et al. Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression. Biochem. Biophys. Res. Commun. 2007, 358:925-930.
284. Yeaman C., Grindstaff K.K., Hansen M.D.H., Nelson W.J. Cell polarity: versatile scaffolds keep things in place. Curr. Biol. 1999, 9:R515-R517.
285. Yeung T., Georges P.C., Flanagan L.A., Marg B., Ortiz M., Funaki M., et al. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil. Cytoskeleton 2005, 60:24-34.
286. Yi R., O'Carroll D., Pasolli H.A., Zhang Z., Dietrich F.S., Tarakhovsky A., et al. Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat. Genet. 2006, 38:356-362.
287. Yook J.I., Li X.-Y., Ota I., Hu C., Kim H.S., Kim N.H., et al. A Wnt-Axin2-GSK3[beta] cascade regulates Snail1 activity in breast cancer cells. Nat. Cell Biol. 2006, 8:1398-1406.
288. Yu L., Border W.A., Anderson I., McCourt M., Huang Y., Noble N.A. Combining TGF-[beta] inhibition and angiotensin II blockade results in enhanced antifibrotic effect. Kidney Int. 2004, 66:1774-1784.
289. Yu W., Kamara H., Svoboda K.K.H. The role of twist during palate development. Dev. Dyn. 2008, 237:2716-2725.
290. Zagris N., Chung A.E., Stavridis V. Entactin and laminin gamma1-chain gene expression in the early chick embryo. Int. J. Dev. Biol. 2005, 49:65-70.
291. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., McMullen J.R., Gustafsson E., et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 2007, 13:952-961.
292. Zeisberg M., Maeshima Y., Mosterman B., Kalluri R. Renal fibrosis: extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am. J. Pathol. 2002, 160:2001-2008.
293. Zeisberg M., Neilson E.G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 2009, 119:1429-1437.
294. Zeisberg M., Shah A.A., Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J. Biol. Chem. 2005, 280:8094-8100.
295. Zeisberg M., Strutz F., Müller G.A. Renal fibrosis: an update. Curr. Opin. Nephrol. Hypertens. 2001, 10:315-320.
296. Zeisberg M., Yang C., Martino M., Duncan M.B., Rieder F., Tanjore H., et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 2007, 282:23337-23347.
297. Zhang C., Klymkowsky M.W. Unexpected functional redundancy between Twist and Slug (Snail2) and their feedback regulation of NF-[kappa]B via Nodal and Cerberus. Dev. Biol. 2009, 331:340-349.
298. Zhang H., Akman H.O., Smith E.L.P., Zhao J., Murphy-Ullrich J.E., Batuman O.A. Cellular response to hypoxia involves signaling via Smad proteins. Blood 2003, 101:2253-2260.
299. Zhang X.-H., Yan M., Liu L., Wu T.-J., Ma L.-L., Wang L.-X. Expression of discoidin domain receptors (DDR2) in alcoholic liver fibrosis in rats. Arch. Med. Res. 2010, 41:586-592.
300. Zhou B.P., Deng J., Xia W., Xu J., Li Y.M., Gunduz M., et al. Dual regulation of Snail by GSK-3[beta]-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 2004, 6:931-940.
301. Zhuge Y., Xu J. Rac1 mediates type I collagen-dependent MMP-2 activation. J. Biol. Chem. 2001, 276:16248-16256.
302. Ziyadeh F.N., Hoffman B.B., Han D.C., Iglesias-de la Cruz M.C., Hong S.W., Isono M., et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice. Proc. Natl. Acad. Sci. USA 2000, 97:8015-8020.